How Do I Find a TRT-Friendly Doctor? (TRT Q&As)
Timeline
Dr. O’Connor recommends being completely honest, respectful, and clear that the goal is shared medical management rather than pressuring the doctor to prescribe. He says the physician may agree to monitor health and labs even if they are not comfortable prescribing testosterone or managing anabolic steroid use.
The caller is using about 75 mg per week and feels well, but his total and free testosterone are slightly supraphysiologic. Dr. O’Connor says treatment should focus on the lowest effective dose, symptoms, sexual function, blood pressure, blood counts, and the broader ABCDs rather than lowering the dose simply because one testosterone value is slightly high.
After learning that the caller previously had a traumatic renal artery event with partial loss of kidney function, Dr. O’Connor treats him as a more complex case. He recommends being more conservative with hemoglobin and hematocrit, monitoring iron studies closely, and using the lowest effective testosterone dose.
The caller wants objective benchmarks after making major lifestyle and medication changes for cardiovascular disease. Dr. O’Connor discusses coronary calcium scoring, CT angiography, HeartFlow FFR analysis, cholesterol management, blood pressure, and continued follow-up as ways to assess whether the disease is stable or progressing.
The caller reports a family history of thalassemia, very high RBC counts, and very low iron while using androgens. Dr. O’Connor explains that thalassemia can complicate androgen-induced erythrocytosis and warns that repeated phlebotomy may further deplete iron, so hematology input and careful monitoring are important.
Dr. O’Connor explains that abnormal hemoglobin and altered red blood cell turnover from thalassemia may potentially distort A1C results. He says fasting glucose and the broader metabolic picture may be more informative when A1C does not match consistently normal glucose readings.
Video Summary
This Ask The Doc live Q&A focuses on how clinicians evaluate testosterone therapy using symptoms, labs, and overall health context together. The conversation emphasizes why lab values must be interpreted within a broader clinical picture rather than treated as isolated targets. Energy, mood, sexual function, and physical performance are discussed as overlapping signals. The session explains how treatment goals evolve over time rather than remaining fixed. Clinical judgment is highlighted as essential when managing variability between individuals. Viewers gain clarity on why protocol-driven care often falls short. Education is reinforced as the foundation of informed decision-making.
Safety and monitoring considerations are explored in depth throughout the session. Topics include estradiol balance, hematocrit trends, and cardiometabolic risk awareness during hormone therapy. The discussion explains why gradual changes are often preferred over abrupt intervention. Baseline health factors such as weight, insulin resistance, and cardiovascular history are incorporated into assessment. Clinicians emphasize proportional responses to lab movement. Longitudinal data patterns are prioritized over single results. This approach reflects contemporary standards of responsible hormone care.
Sexual health questions appear repeatedly, linking hormone balance with vascular and prostate considerations. Erectile dysfunction is framed as a multifactorial issue rather than a single-hormone problem. Medication options are discussed within broader treatment planning. Prostate screening and urinary symptoms are explained using risk stratification and follow-up context. Alarmist messaging is avoided in favor of clarity. Patient communication is emphasized to support shared decision-making. Personalization remains the central theme.
Drug Callouts
Condition Callouts
Key Takeaways
- Hormone therapy decisions rely on symptom patterns and lab trends rather than single values.
- Estradiol balance can influence tolerance and side effects during testosterone therapy.
- Hematocrit monitoring supports safe long-term treatment.
- Sexual health concerns often reflect overlapping hormonal and vascular factors.
- Personalized follow-up improves clinical outcomes and patient understanding.